Check out Lialda for induction of remission in active mild to moderate UC and maintenance of UC remission. Read safety info including potential kidney. Shire US Manufacturing Inc.: LIALDA is indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and for. Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Lialda (mesalamine).
|Published (Last):||22 April 2009|
|PDF File Size:||15.50 Mb|
|ePub File Size:||8.33 Mb|
|Price:||Free* [*Free Regsitration Required]|
E-mail this page or Web site to a friend or loved one by filling out the form below. Following Your Prescribed Treatment Plan. Tell your inert if you: Shire does not control the content of non-Shire Web sites, and this link does not constitute an endorsement by Shire of the site’s content.
E-mail to a Friend
You may need to adjust your Internet properties within your Web browser software, such as Microsoft Internet Explorer or Mozilla Firefox. Kidney problems have been reported with medications that contain mesalamine, such as Lialda.
All content on this Web site, including text, images, graphics, sound files, and their arrangement, belongs to Shire and is protected by international copyright laws. The information contained in this section of the site is intended for US health care professionals only. See Additional Important Safety Information. E-mail this page only.
Talk to your doctor about why Lialda may be right for you. Important Safety Information Do not take Lialda mesalamine if you are allergic to salicylates, such as aspirin, or medications that contain aspirin; aminosalicylates; mesalamine; or any other ingredients in Lialda.
All fields are required. Cookies are required to use some elements of this Web site.
Ulcerative Colitis (UC) Treatment | Lialda® (mesalamine)
Please see Full Prescribing Information for Lialda mesalamine. This site is intended solely for US residents and is governed solely by US laws and government regulations. Click “Cancel” to return or “OK” to continue.
Lialda is a prescription medication approved for the induction of remission in patients with active, mild to moderate ulcerative colitis UC and for the maintenance of remission of UC. In clinical studies of Lialda, inflammation of the pancreas also occurred. If this happens to you, your doctor may tell you to stop taking Lialda. While Shire US Inc. For the induction of remission in patients with active, mild to moderate ulcerative colitis UC and for packagr maintenance of remission of UC.
Click OK if you are a health care professional. You are encouraged to report negative packaage effects of prescription drugs to the FDA.